U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 31 - 40 of 83

Fentanyl Drug Checking and Screening: Roundtable on Clinical Perspectives Summary Report

This document summarizes the discussion from the meeting of clinicians and researchers who are knowledgeable about screening for fentanyl and other drugs, primarily in health care settings. The focus of the meeting was to understand clinician/researcher perspectives about clinical fentanyl testing and distribution of fentanyl test strips (FTS) to patients and discuss next steps for technology development, research, and practice.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF
File Size
562 KB

Fentanyl Drug Checking and Screening: Roundtable on Community Perspectives Summary Report

These proceedings summarize the discussion from the harm reduction community roundtable and supplemental individual interviews, inclusive of representatives from national and local harm reduction organizations, state and local government agencies, tribal organizations, and researchers who have experience distributing fentanyl test strips (FTS) or are knowledgeable about FTS specifically or drug checking more generally.

Format
Report/Paper/Issue Brief
Audience
Behavioral Health Providers
Communities
Medical Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF
File Size
593 KB

Food and Drug Administration Overdose Prevention Framework

The FDA Overdose Prevention Framework consists of four overarching priorities that align with the U.S. Department of Health & Human Services' Overdose Prevention Strategy to address the public health emergency as it continues to evolve.
Format
Toolkit
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Food and Drug Administration (FDA)
Year
Resource Type
PDF
File Size
146 KB

Tips for Teens: The Truth about Alcohol (Spanish Version)

This Spanish language fact sheet for teens provides facts about alcohol. It describes short- and long-term effects and helps dispel common myths. It also can be used by prevention professionals, educators, health care providers, and others who come in contact with teens on a regular basis.
Format
Fact Sheet/Brochure
Audience
Children
Schools
Communities
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF
File Size
2.07 MB

Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019-2020

This report describes changes in drug overdose death rates from 2019 to 2020, stratified by sex, age group, and race and ethnicity. In addition, it examines differences in circumstances surrounding drug overdose, and assesses differences in overdose death rates by county-level income inequality and availability of mental health treatment providers and providers of medications for opioid use disorder.
Format
Report/Paper/Issue Brief
Audience
Policymakers and Payers
States
Communities
Source
Centers for Disease Control and Prevention (CDC)
Year
Resource Type
PDF
File Size
194 KB

Guidance on Handling the Increasing Prevalence of Drugs Adulterated or Laced with Fentanyl

This paper offers principle and recommendations for remediating the impacts of the rising rates of drugs adulterated or laced with fentanyl.

Format
Report/Paper/Issue Brief
Audience
Behavioral Health Providers
Communities
Medical Providers
Other Team Members
Policymakers and Payers
States
Source
National Council For Mental Wellbeing
Year
Resource Type
PDF
File Size
316 KB